Concepedia

Mitchell Muniak

MM

3

Publications

86

Citations

3

H-Index

2020

Active since

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Mitchell Muniak is an author at The Ohio State University specializing in clinical trials, molecular oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2020–2023

3

Publications

3

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak et al. · BMC Cancer · 2020 · 58 citations · Full text

Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq Data

Rebecca Hoyd, Caroline E. Wheeler, YunZhou Liu et al. · Cancer Research Communications · 2023 · 17 citations · Full text

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Marium Husain, Menglin Xu, Sandipkumar Patel et al. · Journal of Clinical Oncology · 2021 · 11 citations

, , +19

Rows per page

1–3 of 3